首页> 外文OA文献 >The PVSG/WHO versus the Rotterdam European clinical, molecular and pathological diagnostic criteria for the classification of myeloproliferative disorders and myeloproliferative neoplasms (MPD/MPN): From Dameshek to Georgii, Vainchenker and Michiels 1950-2018

【2h】

The PVSG/WHO versus the Rotterdam European clinical, molecular and pathological diagnostic criteria for the classification of myeloproliferative disorders and myeloproliferative neoplasms (MPD/MPN): From Dameshek to Georgii, Vainchenker and Michiels 1950-2018

机译：与鹿特丹欧洲临床，分子和病理诊断标准的PVSG /谁为髓原疾病和髓原瘤的分类（MPD / MPN）：从DameShek到Georgii，Vainchenker和Michiels 1950-2018

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Jan Jacques Michiels; Hendrik De Raeve;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Changing Concepts of Diagnostic Criteria of Myeloproliferative Disorders and the Molecular Etiology and Classification of Myeloproliferative Neoplasms: From Dameshek 1950 to Vainchenker 2005 and Beyond [J] . Michiels Jan Jacques, Berneman Zwi, Schroyens Wilfried, Acta Haematologica . 2015,第1期

机译：骨髓增生异常诊断标准的不断变化的概念以及骨髓增生性肿瘤的分子病因和分类：从Dameshek 1950年到Vainchenker 2005年及以后
2. The European Clinical, Molecular, and Pathological (ECMP) Criteria and the 2007/2008 Revisions of the World Health Organization for the Diagnosis, Classification, and Staging of Prefibrotic Myeloproliferative Neoplasms Carrying the JAK2V617F Mutation [J] . Jan Jacques Michiels, Fibo Ten Kate, King H. Lam, Turkish Journal of Hematology . 2014,第3期

机译：欧洲临床，分子和病理学（ECMP）标准以及世界卫生组织对携带JAK2V617F突变的纤维化前骨髓增生性肿瘤的诊断，分类和分期的2007/2008修订版
3. Proposed criteria for response assessment in patients treated in clinical trials for myeloproliferative neoplasms in blast phase (MPN-BP): Formal recommendations from the post-myeloproliferative neoplasm acute myeloid leukemia consortium [J] . MascarenhasJ., HeaneyM.L., NajfeldV., Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis . 2012,第12期

机译：初生阶段骨髓增生性肿瘤临床试验中治疗患者的反应评估建议标准（MPN-BP）：骨髓增生后肿瘤急性髓样白血病联合会的正式建议
4. 2016 WHO Clinical Molecular and Pathological Criteria for Classification and Staging of Myeloproliferative Neoplasms (MPN) Caused by MPN Driver Mutations in the JAK2 MPL and CALR Genes in the Context of New 2016 WHO Classification: Prognostic and Therapeutic Implications [O] . Jan Jacques Michiels, Mihaela Tevet, Adrian Trifa, 2016

机译：在2016年新的WHO分类中由JAK2MPL和CALR基因中的MPN驱动基因突变引起的骨髓增生性肿瘤（MPN）的分类和分期的2016 WHO临床分子和病理学标准：预后和治疗意义
5. European Clinical Laboratory, Molecular and Pathological (ECMP) criteria for prefibrotic JAK2V617F-Thrombocythemia and Polycythemia Vera versus MPL515- and CALR-Thrombocythemia and Myelofibrosis: From Dameshek to Michiels 1950-2018 [O] . Michiels Jan Jacques 2019

机译：欧洲临床实验室，分子和病理学（ECMP）前jak2v617f-血小板和多胆症Vera与mpl515和calr-zhomcythemia和myelofibrys的标准：从Dameshek到Michiels 1950-2018

The PVSG/WHO versus the Rotterdam European clinical, molecular and pathological diagnostic criteria for the classification of myeloproliferative disorders and myeloproliferative neoplasms (MPD/MPN): From Dameshek to Georgii, Vainchenker and Michiels 1950-2018

著录项

相似文献

相关主题

期刊订阅